Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yandex transferred its Russian assets to ICAO Yandex

1/23/24 YNDX

PhosAgro concludes SPIC 2.0 for the development of the Balakovo Complex

1/23/24 PHOR

Acron increased marketable product output by 0.5% in 2023

1/22/24 AKRN

Rosimushchestvo increased its stake in TGK-2 to 83.4%

1/22/24 TGKB

Sberbank intends to integrate its services into Lada cars

1/22/24 SBER

Fire in Ust-Luga damaged Novatek's gas terminal

1/22/24 NVTK

Qiwi sells Russian business to Group CEO Andrey Protopopov

1/19/24 QIWI

Investors Association wants to establish requirements for the content of dividend policy

1/19/24 MOEX

LSR doubled real estate sales

1/19/24 LSRG

Eurotrans shareholders to hand over ₽1.4 billion to the company

1/19/24 EUTR